M 944 (Divalproex Sodium Delayed-Release 250 mg)
Pill with imprint M 944 is Blue, Round and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..
Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 944
- M 944
- 250 mg
- 11.00 mm
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
FD&C Blue No. 2,
FD&C Yellow No. 6,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00378-1044||Mylan Pharmaceuticals Inc.|
|51079-0474||UDL Laboratories Inc.|
More about divalproex sodium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 415 Reviews
- Drug class: fatty acid derivative anticonvulsants
- FDA Alerts (5)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.